A new company formed by merchant bankers
Viscogliosi Bros. LLC (VB) to create a single source of small bone & joint
implant products will debut at this month's American Academy of Orthopaedic
Surgeons annual convention (Feb.23-27).
During the past year, VB has quietly acquired US and European companies
and technologies in the 'small bone' field, as well as licensing and
distribution rights for a unique Swedish biological treatment for arthritic
thumbs and 'Actipore' porous metal technology from Biorthex, Inc.,
Montreal, Canada. The group has been formed by VB under the new entity, Small
Bone Innovations, LLC (SBI), headquartered in New York.
VB is regarded as a pioneering force in the discovery and development of
promising orthopaedic technologies. In 2003, the firm sold its artificial
spine disc company, Spine Solutions, Inc., to Synthes, Inc., of Switzerland,
for $350 million. The firm has been credited with creating the concept of
spine arthroplasty as an alternative to fusion in repairing spinal disc
Anthony G. Viscogliosi, Chairman and CEO of SBI and a principal of VB,
said: "We recognized the potential for growth and innovation in small bone
surgery a decade ago. With the prevalence of arthritis in our aging
population, surgical techniques are a compelling alternative to drug therapy.
As a result, we have translated that vision into a company quite different
from competitors in the sector by becoming a vertically integrated, single
source of products and technology for small bone & joint surgeons."
SBI has more than 50 employees in the US and Europe and has assembled a
broad portfolio of FDA-approved implants to treat both small bone & joint
degenerative diseases and trauma patients.